Sky Capital Announces Clinical Trial Approval for AST

Sky Holdings, listed on the AIM market of the London Stock Exchange, announced that its 18 percent owned investment, Advanced Spinal Technologies (AST), has received approval from the Western Institutional Review Board to commence clinical trials for its Technology-Assisted Micro-Mobilization and Reflex Stimulator (TAMARS) -- previously known as the pamm3 MicroManipulator. AST holds the exclusive license to the intellectual property and commercial rights relating to TAMARS in the U.S., Europe, Australia, Japan and all other countries of the world other than the UK and the Republic of Ireland.

mysan.de (http://www.mysan.de/article99972.html)